Erratum to: Expression-based drug screening of neural progenitor cells from individuals with schizophrenia (Nature Communications, (2018), 9, 1, (4412), 10.1038/s41467-018-06515-4)

Benjamin Readhead, Brigham J. Hartley, Brian J. Eastwood, David A. Collier, David Evans, Richard Farias, Ching He, Gabriel Hoffman, Pamela Sklar, Joel T. Dudley, Eric E. Schadt, Radoslav Savić, Kristen J. Brennand

Research output: Contribution to journalComment/debate

1 Scopus citations

Abstract

In the originally published version of this Article, the affiliation details for Eric E. Schadt and Radoslav Savic incorrectly omitted ‘Sema4, a Mount Sinai venture, Stamford, Connecticut, USA’. This has been corrected in both the PDF and HTML versions of the Article.

Original languageEnglish (US)
Article number4926
JournalNature communications
Volume9
Issue number1
DOIs
StatePublished - Dec 1 2018

ASJC Scopus subject areas

  • Chemistry(all)
  • Biochemistry, Genetics and Molecular Biology(all)
  • Physics and Astronomy(all)

Fingerprint Dive into the research topics of 'Erratum to: Expression-based drug screening of neural progenitor cells from individuals with schizophrenia (Nature Communications, (2018), 9, 1, (4412), 10.1038/s41467-018-06515-4)'. Together they form a unique fingerprint.

  • Cite this

    Readhead, B., Hartley, B. J., Eastwood, B. J., Collier, D. A., Evans, D., Farias, R., He, C., Hoffman, G., Sklar, P., Dudley, J. T., Schadt, E. E., Savić, R., & Brennand, K. J. (2018). Erratum to: Expression-based drug screening of neural progenitor cells from individuals with schizophrenia (Nature Communications, (2018), 9, 1, (4412), 10.1038/s41467-018-06515-4). Nature communications, 9(1), [4926]. https://doi.org/10.1038/s41467-018-07326-3